Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 987K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Lan, H. Y. Articles by Atkins, R. C. Search for Related Content PubMed PubMed Citation Articles by Lan, H. Y. Articles by Atkins, R. C. Pubmed/NCBI databases Substance via MeSH Social Bookmarking                            What's this?

Article

Hui Y. Lan^*, Michael Bacher, Niansheng Yang^*, Wei Mu^*, David J. Nikolic-Paterson^*, Christine Metz, Andreas Meinhardt, Richard Bucala, and Robert C. Atkins^*

From the ^* Department of Nephrology and the Institute for Reproduction and Development, Monash Medical Centre, Clayton, Victoria 3168, Australia; Picower Institute for Medical Research, Manhasset, New York 11030

Macrophage migration inhibitory factor (MIF) plays a pivotal role in the inflammatory response in endotoxemia and in the delayed-type hypersensitivity response, but its potential as a regulator of immunologically induced disease is unknown. We have addressed this issue by administering a neutralizing anti-MIF antibody in a rat model of immunologically induced crescentic anti-glomerular basement membrane (GBM) glomerulonephritis. Six individual experiments using paired inbred littermates were performed. Rats were primed with rabbit immunoglobulin on day –5 and then injection with rabbit anti–rat GBM serum on day 0. Pairs of animals were treated with anti-MIF or a control monoclonal antibody from the time of anti-GBM serum administration until being killed 14 d later. Control antibody-treated animals developed severe proteinuria and renal function impairment with severe histological damage due to marked leukocytic infiltration and activation within the kidney. In contrast, anti-MIF treatment substantially reduced proteinuria, prevented the loss of renal function, significantly reduced histological damage including glomerular crescent formation, and substantially inhibited renal leukocytic infiltration and activation (all P <0.001 compared with control treatment). Inhibition of renal disease by anti-MIF treatment was attributed to preventing the marked upregulation of interleukin-1β, leukocyte adhesion molecules including intercellular adhesion molecule-1 and vascular cell adhesion molecule-1, and inducible nitric oxide synthase expression seen in the control antibody-treated animals. This inhibition of progressive renal injury was mirrored by the complete suppression of the skin delayed-type hypersensitivity response to the challenge antigen (rabbit IgG). Interestingly, anti-MIF treatment did not effect the secondary antibody response or immune deposition within the kidney, indicating that MIF participates in cellular-based immunity in this primed macrophage-dependent anti-GBM glomerulonephritis. In conclusion, this study has demonstrated a key regulatory role for MIF in the pathogenesis of immunologically induced kidney disease. These results argue that blocking MIF activity may be of benefit in the treatment of human rapidly progressive glomerulonephritis, and suggest that MIF may be important in immune-mediated disease generally.

¹Abbreviations used in this paper: APAAP, alkaline phosphatase anti-alkaline phosphatase; DIG, digoxigenin; DTH, delayed-type hypersensitivity; GBM, glomerular basement membrane: GCS, glomerular cross-section; H&E, hematoxylin and eosin; ICAM, intercellular adhesion molecule; iNOS, inducible nitric oxide synthase; MIF, macrophage migration inhibitory factor; PAP, peroxidase anti-peroxidase; PAS, periodic acid– Schiff reagent; PLP, paraformaldehyde–lysine–periodate

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Chung, A. C. K., Huang, X. R., Zhou, L., Heuchel, R., Lai, K. N., Lan, H. Y. (2009). Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. Nephrol Dial Transplant 24: 1443-1454 [Abstract] [Full Text]  
• Paiva, C. N., Arras, R. H., Magalhaes, E. S., Alves, L. S., Lessa, L. P., Silva, M. H., Ejzemberg, R., Canetti, C., Bozza, M. T. (2009). Migration inhibitory factor (MIF) released by macrophages upon recognition of immune complexes is critical to inflammation in Arthus reaction. J. Leukoc. Biol. 85: 855-861 [Abstract] [Full Text]  
• Huang, L., Garcia, G., Lou, Y., Zhou, Q., Truong, L. D., DiMattia, G., Lan, X. R., Lan, H. Y., Wang, Y., Sheikh-Hamad, D. (2009). Anti-Inflammatory and Renal Protective Actions of Stanniocalcin-1 in a Model of Anti-Glomerular Basement Membrane Glomerulonephritis. Am. J. Pathol. 174: 1368-1378 [Abstract] [Full Text]  
• Wong, B. L.W., Zhu, S.-L., Huang, X. R., Ma, J., Xia, H. H.X., Bucala, R., Wong, B. C.Y., Lan, H. Y. (2009). Essential Role for Macrophage Migration Inhibitory Factor in Gastritis Induced by Helicobacter pylori. Am. J. Pathol. 174: 1319-1328 [Abstract] [Full Text]  
• Filip, A.-M., Klug, J., Cayli, S., Frohlich, S., Henke, T., Lacher, P., Eickhoff, R., Bulau, P., Linder, M., Carlsson-Skwirut, C., Leng, L., Bucala, R., Kraemer, S., Bernhagen, J., Meinhardt, A. (2009). Ribosomal Protein S19 Interacts with Macrophage Migration Inhibitory Factor and Attenuates Its Pro-inflammatory Function. J. Biol. Chem. 284: 7977-7985 [Abstract] [Full Text]  
• Martin, J., Duncan, F. J., Keiser, T., Shin, S., Kusewitt, D. F., Oberyszyn, T., Satoskar, A. R., VanBuskirk, A. M. (2009). Macrophage migration inhibitory factor (MIF) plays a critical role in pathogenesis of ultraviolet-B (UVB) -induced nonmelanoma skin cancer (NMSC). FASEB J. 23: 720-730 [Abstract] [Full Text]  
• Zernecke, A., Bernhagen, J., Weber, C. (2008). Macrophage Migration Inhibitory Factor in Cardiovascular Disease. Circulation 117: 1594-1602 [Abstract] [Full Text]  
• Huang, X. R., Chung, A. C.K., Zhou, L., Wang, X. J., Lan, H. Y. (2008). Latent TGF-{beta}1 Protects Against Crescentic Glomerulonephritis. J. Am. Soc. Nephrol. 19: 233-242 [Abstract] [Full Text]  
• Ferro, E. A. V., Mineo, J. R., Ietta, F., Bechi, N., Romagnoli, R., Silva, D. A. O., Sorda, G., Bevilacqua, E., Paulesu, L. R. (2008). Macrophage Migration Inhibitory Factor Is Up-Regulated in Human First-Trimester Placenta Stimulated by Soluble Antigen of Toxoplasma gondii, Resulting in Increased Monocyte Adhesion on Villous Explants. Am. J. Pathol. 172: 50-58 [Abstract] [Full Text]  
• Wang, W., Soltero, L., Zhang, P., Huang, X. R., Lan, H. Y., Adrogue, H. J. (2007). Renal inflammation is modulated by potassium in chronic kidney disease: possible role of Smad7. Am. J. Physiol. Renal Physiol. 293: F1123-F1130 [Abstract] [Full Text]  
• Toh, M.-L., Aeberli, D., Lacey, D., Yang, Y., Santos, L. L., Clarkson, M., Sharma, L., Clyne, C., Morand, E. F. (2006). Regulation of IL-1 and TNF Receptor Expression and Function by Endogenous Macrophage Migration Inhibitory Factor. J. Immunol. 177: 4818-4825 [Abstract] [Full Text]  
• Han, S.-Y., Kim, C.-H., Kim, H.-S., Jee, Y.-H., Song, H.-K., Lee, M.-H., Han, K.-H., Kim, H.-K., Kang, Y.-S., Han, J.-Y., Kim, Y.-S., Cha, D.-R. (2006). Spironolactone Prevents Diabetic Nephropathy through an Anti-Inflammatory Mechanism in Type 2 Diabetic Rats. J. Am. Soc. Nephrol. 17: 1362-1372 [Abstract] [Full Text]  
• Tedgui, A., Mallat, Z. (2006). Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways. Physiol. Rev. 86: 515-581 [Abstract] [Full Text]  
• Amin, M. A., Haas, C. S., Zhu, K., Mansfield, P. J., Kim, M. J., Lackowski, N. P., Koch, A. E. (2006). Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NF{kappa}B. Blood 107: 2252-2261 [Abstract] [Full Text]  
• Kimura, K., Nagaki, M., Nishihira, J., Satake, S., Kuwata, K., Moriwaki, H. (2006). Role of macrophage migration inhibitory factor in hepatitis B virus-specific cytotoxic-T-lymphocyte-induced liver injury.. CVI 13: 415-419 [Abstract] [Full Text]  
• Cvetkovic, I., Al-Abed, Y., Miljkovic, D., Maksimovic-Ivanic, D., Roth, J., Bacher, M., Lan, H. Y., Nicoletti, F., Stosic-Grujicic, S. (2005). Critical Role of Macrophage Migration Inhibitory Factor Activity in Experimental Autoimmune Diabetes. Endocrinology 146: 2942-2951 [Abstract] [Full Text]  
• Odobasic, D., Kitching, A. R., Semple, T. J., Timoshanko, J. R., Tipping, P. G., Holdsworth, S. R. (2005). Glomerular Expression of CD80 and CD86 Is Required for Leukocyte Accumulation and Injury in Crescentic Glomerulonephritis. J. Am. Soc. Nephrol. 16: 2012-2022 [Abstract] [Full Text]  
• Wang, W., Huang, X. R., Li, A. G., Liu, F., Li, J.-H., Truong, L. D., Wang, X. J., Lan, H. Y. (2005). Signaling Mechanism of TGF-{beta}1 in Prevention of Renal Inflammation: Role of Smad7. J. Am. Soc. Nephrol. 16: 1371-1383 [Abstract] [Full Text]  
• Kong, Y.-Z., Huang, X.-R., Ouyang, X., Tan, J.-J., Fingerle-Rowson, G., Bacher, M., Mu, W., Scher, L. A., Leng, L., Bucala, R., Lan, H. Y. (2005). Evidence for vascular macrophage migration inhibitory factor in destabilization of human atherosclerotic plaques. Cardiovasc Res 65: 272-282 [Abstract] [Full Text]  
• Weber, C., Schober, A., Zernecke, A. (2004). Chemokines: Key Regulators of Mononuclear Cell Recruitment in Atherosclerotic Vascular Disease. Arterioscler. Thromb. Vasc. Bio. 24: 1997-2008 [Abstract] [Full Text]  
• Leung, J. C. K., Chan, L. Y. Y., Tsang, A. W. L., Liu, E. W. L., Lam, M. F., Tang, S. C. W., Lai, K. N. (2004). Anti-macrophage migration inhibitory factor reduces transforming growth factor-{beta}1 expression in experimental IgA nephropathy. Nephrol Dial Transplant 19: 1976-1985 [Abstract] [Full Text]  
• Razzaque, M. S., Foster, C. S., Ahmed, A. R. (2004). Role of Macrophage Migration Inhibitory Factor in Conjunctival Pathology in Ocular Cicatricial Pemphigoid. IOVS 45: 1174-1181 [Abstract] [Full Text]  
• Chen, Z., Sakuma, M., Zago, A. C., Zhang, X., Shi, C., Leng, L., Mizue, Y., Bucala, R., Simon, D. I. (2004). Evidence for a Role of Macrophage Migration Inhibitory Factor in Vascular Disease. Arterioscler. Thromb. Vasc. Bio. 24: 709-714 [Abstract] [Full Text]  
• Frosch, M., Vogl, T., Waldherr, R., Sorg, C., Sunderkotter, C., Roth, J. (2004). Expression of MRP8 and MRP14 by macrophages is a marker for severe forms of glomerulonephritis. J. Leukoc. Biol. 75: 198-206 [Abstract] [Full Text]  
• Schober, A., Bernhagen, J., Thiele, M., Zeiffer, U., Knarren, S., Roller, M., Bucala, R., Weber, C. (2004). Stabilization of Atherosclerotic Plaques by Blockade of Macrophage Migration Inhibitory Factor After Vascular Injury in Apolipoprotein E-Deficient Mice. Circulation 109: 380-385 [Abstract] [Full Text]  
• Fingerle-Rowson, G., Petrenko, O., Metz, C. N., Forsthuber, T. G., Mitchell, R., Huss, R., Moll, U., Muller, W., Bucala, R. (2003). The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc. Natl. Acad. Sci. USA 100: 9354-9359 [Abstract] [Full Text]  
• Hudson, B. G., Tryggvason, K., Sundaramoorthy, M., Neilson, E. G. (2003). Alport's Syndrome, Goodpasture's Syndrome, and Type IV Collagen. NEJM 348: 2543-2556 [Full Text]  
• Yu, C.-M., Lai, K. W.-H., Chen, Y.-X., Huang, X.-R., Lan, H. Y. (2003). Expression of Macrophage Migration Inhibitory Factor in Acute Ischemic Myocardial Injury. J. Histochem. Cytochem. 51: 625-631 [Abstract] [Full Text]  
• Ikezumi, Y., Atkins, R. C., Nikolic-Paterson, D. J. (2003). Interferon-{gamma} Augments Acute Macrophage-Mediated Renal Injury Via a Glucocorticoid-Sensitive Mechanism. J. Am. Soc. Nephrol. 14: 888-898 [Abstract] [Full Text]  
• Denkinger, C. M., Denkinger, M., Kort, J. J., Metz, C., Forsthuber, T. G. (2003). In Vivo Blockade of Macrophage Migration Inhibitory Factor Ameliorates Acute Experimental Autoimmune Encephalomyelitis by Impairing the Homing of Encephalitogenic T Cells to the Central Nervous System. J. Immunol. 170: 1274-1282 [Abstract] [Full Text]  
• Bacher, M., Schrader, J., Thompson, N., Kuschela, K., Gemsa, D., Waeber, G., Schlegel, J. (2003). Up-Regulation of Macrophage Migration Inhibitory Factor Gene and Protein Expression in Glial Tumor Cells during Hypoxic and Hypoglycemic Stress Indicates a Critical Role for Angiogenesis in Glioblastoma Multiforme. Am. J. Pathol. 162: 11-17 [Abstract] [Full Text]  
• Fingerle-Rowson, G., Koch, P., Bikoff, R., Lin, X., Metz, C. N., Dhabhar, F. S., Meinhardt, A., Bucala, R. (2003). Regulation of Macrophage Migration Inhibitory Factor Expression by Glucocorticoids in Vivo. Am. J. Pathol. 162: 47-56 [Abstract] [Full Text]  
• Kitching, A. R., Ru Huang, X., Turner, A. L., Tipping, P. G., Dunn, A. R., Holdsworth, S. R. (2002). The Requirement for Granulocyte-Macrophage Colony-Stimulating Factor and Granulocyte Colony-Stimulating Factor in Leukocyte-Mediated Immune Glomerular Injury. J. Am. Soc. Nephrol. 13: 350-358 [Abstract] [Full Text]  
• Senter, P. D., Al-Abed, Y., Metz, C. N., Benigni, F., Mitchell, R. A., Chesney, J., Han, J., Gartner, C. G., Nelson, S. D., Todaro, G. J., Bucala, R. (2002). Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites. Proc. Natl. Acad. Sci. USA 10.1073/pnas.011569399v1 [Abstract] [Full Text]  
• Brown, F. G., Nikolic-Paterson, D. J., Hill, P. A., Isbel, N. M., Dowling, J., Metz, C. M., Atkins, R. C. (2002). Urine Macrophage Migration Inhibitory Factor Reflects the Severity of Renal Injury in Human Glomerulonephritis. J. Am. Soc. Nephrol. 13: S7-13 [Abstract] [Full Text]  
• Beishuizen, A., Thijs, L. G., Haanen, C., Vermes, I. (2001). Macrophage Migration Inhibitory Factor and Hypothalamo-Pituitary-Adrenal Function during Critical Illness. J. Clin. Endocrinol. Metab. 86: 2811-2816 [Abstract] [Full Text]  
• Satoskar, A. R., Bozza, M., Rodriguez Sosa, M., Lin, G., David, J. R. (2001). Migration-Inhibitory Factor Gene-Deficient Mice Are Susceptible to Cutaneous Leishmania major Infection. Infect. Immun. 69: 906-911 [Abstract] [Full Text]  
• Lin, S.-G., Yu, X.-Y., Chen, Y.-X., Huang, X. R., Metz, C., Bucala, R., Lau, C.-P., Lan, H. Y. (2000). De Novo Expression of Macrophage Migration Inhibitory Factor in Atherogenesis in Rabbits. Circ. Res. 87: 1202-1208 [Abstract] [Full Text]  
• Yang, Y., Degranpré, P., Kharfi, A., Akoum, A. (2000). Identification of Macrophage Migration Inhibitory Factor as a Potent Endothelial Cell Growth-Promoting Agent Released by Ectopic Human Endometrial Cells. J. Clin. Endocrinol. Metab. 85: 4721-4727 [Abstract] [Full Text]  
• Romero, M., Mosquera, J., Novo, E., Fernandez, L., Parra, G. (1999). Erythrogenic toxin type B and its precursor isolated from nephritogenic streptococci induce leukocyte infiltration in normal rat kidneys. Nephrol Dial Transplant 14: 1867-1874 [Abstract] [Full Text]  
• Mitchell, R. A., Metz, C. N., Peng, T., Bucala, R. (1999). Sustained Mitogen-activated Protein Kinase (MAPK) and Cytoplasmic Phospholipase A2 Activation by Macrophage Migration Inhibitory Factor (MIF). REGULATORY ROLE IN CELL PROLIFERATION AND GLUCOCORTICOID ACTION. J. Biol. Chem. 274: 18100-18106 [Abstract] [Full Text]  
• COUSER, W. G. (1999). Sensitized Cells Come of Age: A New Era in Renal Immunology withImportant Therapeutic Implications. J. Am. Soc. Nephrol. 10: 664-665 [Full Text]  
• Bozza, M., Satoskar, A. R., Lin, G., Lu, B., Humbles, A. A., Gerard, C., David, J. R. (1999). Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis. JEM 189: 341-346 [Abstract] [Full Text]  
• Calandra, T., Spiegel, L. A., Metz, C. N., Bucala, R. (1998). Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc. Natl. Acad. Sci. USA 95: 11383-11388 [Abstract] [Full Text]  
• Juttner, S., Bernhagen, J., Metz, C. N., Rollinghoff, M., Bucala, R., Gessner, A. (1998). Migration Inhibitory Factor Induces Killing of Leishmania major by Macrophages: Dependence on Reactive Nitrogen Intermediates and Endogenous TNF-{alpha}. J. Immunol. 161: 2383-2390 [Abstract] [Full Text]  
• Senter, P. D., Al-Abed, Y., Metz, C. N., Benigni, F., Mitchell, R. A., Chesney, J., Han, J., Gartner, C. G., Nelson, S. D., Todaro, G. J., Bucala, R. (2002). Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites. Proc. Natl. Acad. Sci. USA 99: 144-149 [Abstract] [Full Text]  
• Burger-Kentischer, A., Goebel, H., Seiler, R., Fraedrich, G., Schaefer, H. E., Dimmeler, S., Kleemann, R., Bernhagen, J., Ihling, C. (2002). Expression of Macrophage Migration Inhibitory Factor in Different Stages of Human Atherosclerosis. Circulation 105: 1561-1566 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS